1、 IDF8 o Ml(2005) S M 8h q顾东风 ReynoldsK 杨文杰 陈恕凤 吴锡桂 段秀芳 蒲晓东 徐丽华吴先萍 陈祥福 魏仁敏 陈娜萦 吴天一 王礼桂 姚才良 牟建军马义峰 王晓飞 WheltonP 何江【K1】 “ 41S3574 B M 8(MS)# 1Fsh qK 。 ZE 20002001 M S3574 M V4 15 540 8 。 S= Uh 2004 Mwi1S MSSMSFss 。 T 3 o9, M -SMSh q16.5%。 M -SMSh q, 3 osY10.0%23.3%; M -Sh q,Z 2Z usY23.3%11.5%, g jh usY
2、23.5%14.7%。SZ MSh q 2Z ,g jh 。 S M M1 8MS。tT4 USs _ S、_ MS 3 ,5%h。【1oM】 8;h q; hTheprevalenceofmetabolic syndrome in the general adult populationaged35-74 years in China GUDong-feng, Reynolds K,YANG Wen-jie, et al. Cardiovascular Institute, Fuwai CardiovascularDisease Hospital, PekingUnion Medical C
3、ollege, Beijing 100037,China【Abstract】 Objective To provideestimatesof the prevalenceof themetabolicsyndromeand itsmain components in the general adult population at theage of 35-74 years in China. Methods Across-sectionalsurvey was conducted in a nationally representative sample of 15 540 Chinese a
4、dultsaged35-74years in 2000-2001. Metabolicsyndromewas definedaccording to theInternational Diabe-tes Federation consensusworldwide definition in 2005. Results Thecrudeprevalence of metabolicsyndromewas16.5%. Theage-standardizedprevalenceofmetabolicsyndromewas10.0%inmenand23.3%in women. Theage-stand
5、ardizedprevalenceof metabolicsyndromewas23.3%innorthernand11.5%in southernChina. Theage-standardizedprevalenceof metabolicsyndromewas23.5%in ur-ban and14.7%inruralarea. Theprevalenceof themetabolicsyndromeandoverweight was higherinnorthern thaninsouthernChina, andhigherin urban thanruralresidents. C
6、onclusion A largepro-portionof Chineseadultshave themetabolicsyndrome. Thepreventionandcontrol of overweight andthemetabolicsyndromeareurgentlywarrantedinordertoreduce thesocietalburdenof cardiovasculardiseasein China.【Keywords】 Metabolicsyndrome;Prevalence;EpidemiologyT:100037 ,SD SSxD Sv5hD5h 8L.
7、i($、 、 I、 Y); STulanevD 3(Reynolds K、WheltonP、 );y 8 D5h ( k); 8vD D5h i( ); + 8f_(5 ); 8 “E 3f_(V); g D( );102 cm, o88 cm; bTG1.7mmol/L(150 mg/dl);HDL-C:30.9, o0.85;/BMI:30kg/m2 ;(2)140/90mm Hg;(3)TG1.7mmol/L(150mg/dl);/HDL-C0.9mmol/L(35 mg/dl)( 3), 1.0 mmol/L184 Uh2005 M13 3 Chin J Diabetes, June2
8、005,Vol 13,No 3(39mg/dl)( o);(4) U( U q20g/min/30mg/g)13 。5 MSl h q , l ( V _5%h、 y q? 3 UhB9 14 。IDFK ol,L| 1 。7 OtS “5 WHOSeL。MS Uh#5%h?h q q9F1 ,7 v64,11,14,15 。Isomaa4MS85%h q1 MS85。o B -QA U,.d5%hBy ,MS 383h B9 314 。B -Q $YsA U,S 3 T|BMIh24.0kg/m2/ V P?h q15%, o5V22%15 。TV ,SM M MS。5%hXS1 y, -
9、j eMS,| t5|9。vATPlSMSh q S, SEM 12 。IDFS,4SB M MSh qK 。MSlS、“4、Yh q s, |T T1 HFi。 SNHANES TAU,vATPS,n M -MSh q23.7%6 。 7,48 20 #20 M ,48 M -3574 W。Lakka14o AU, Uh#5%h N M 38MSh q8.8%(vATP S)14.3%(vWHOS)。S v dTM 。S Bu 8320 M -3092 W8,vATPSMSh q15.4%( 311.2%, o18.6%)16 。 6BSv d118 g 27739 M -3564W8, M
10、Sh q13.3%( 312.7%, o14.2%)17 。TM1, 3 oHDL-C M ( (sY0.9mmol/L/1.0 mmol/L), 3% M9 ,7 M (SBP140 mm HgDBP90mm Hg)17 。 SMSh q 3 oM 6 。7oMSh q 3。s V ? og HDL-Ch q 3,y 3 o M lFs。IDFS H, og、HDL-Ch q 。TV ,SZ MS# BFs#h q ( 2Z , g jh 。S -,、Uhg h qs18 。 2Z#T W J8、8 s V ?s19,20 。 S5#k hZ T A U, 2Z # jh M1,SZ # g
11、 J 19,20 。8 h 、# 、 v T #T 9F,t g 3Z T V ?Ts。5t 3Z TsdA, MSh qsv1 V 3ZTs di b#。TA U S3574 M MSh q。6?Z、 3Z T# J8M9 V d; ?9hq。tTV MSS1 35B。MSh q,Ss _ SMS ,5%h m9。F#1T :美国路易丝安那州新奥尔良杜兰大学:何江(主要负责人), Bazzano L A, CHENJing, MuntnerP, Reynolds K, Whelton PK, andXIN Xue;澳大利亚悉尼大学:MacMahon S(主要负责人), ChapmanN, N
12、eal B, Woodward M, andZHANG Xin-hua;中国医学科学院协和医科大学阜外心血管病医院心血管病研究所:顾东风(主要负责人)、陈恕凤、吴锡桂、甘文奇、宿少勇、刘东海、段秀芳、黄广勇;北京:马义峰、刘秀、田中旗、王晓飞、范光勇、王加强、仇长林;福建:俞玲、蒲晓东、白新胜、黎林森、吴畏;吉林:徐丽华、刘晶、姜玉芝、兰玉华、黄立江、尹怀峰;四川:吴先萍、邓颖、何军、张宁梅、杨晓妍;山东:陈祥福、魏仁敏、刘兴忠、阮槐玉、李明、张长青;广西:陈娜萦、蒙晓宇、韦芳青、徐永芳;青海:吴天一、吉建江、史朝秀、杨萍;湖北:王礼桂、胡虞志、严立、王艳娟;江苏:姚才良、马良才、张钧、185
13、 Uh2005 M13 3 Chin JDiabetes, June2005,Vol 13,No3徐敏皋、周正元;陕西:牟建军、王哲训、李会苍、赵自瑞。 ID1 Murray CJ, Lopez AD. Mortality by cause for eight regions ofthe world:GlobalBurdenof DiseaseStudy. Lancet,1997, 349:1269-1276.2 YaoC, Wu Z, Wu Y. The changing pattern of cardiovasculardiseasesinChina. World Health Stat
14、Q, 1993, 46:113-118.3 Executive summary of thethird report of theNational Choles-terol Education Program (NCEP) expert panel on detection,evaluation, and treatment of high blood cholesterol in adults(AdultTreatment Panel). JAMA,2001, 285:2486-2497.4 IsomaaB, Almgren P, Tuomi T, et al.Cardiovascularm
15、orbidi-tyandmortalityassociatedwith themetabolicsyndrome. Diabe-tesCare,2001,24:683-689.5 TrevisanM, LiuJ, BahsasFB, et al. SyndromeX andmortali-ty:a population-based study. Risk factor and life expectancyresearch group. AmJ Epidemiol,1998,148:958-966.6 Ford ES, Giles WH, Dietz WH. Prevalence of the
16、metabolicsyndromeamong US adults:findings from the third NationalHealth andNutrition ExaminationSurvey. JAMA, 2002, 287:356-359.7 Perloff D, GrimC, FlackJ, et al. Human bloodpressuredeter-mination by sphygmomanometry. Circulation, 1993, 88:2460-2470.8 Friedewald WT, Levy RI, Fredrickson DS. Estimati
17、on of theconcentration of low-density lipoprotein cholesterol in plasma,without use of the preparative ultracentrifuge. Clin Chem,1972,18:499-502.9 Myers GL, CooperGR, Winn CL, et al. TheCenters forDis-easeControl-National Heart, Lung and Blood Institute LipidStandardizationProgram. An approach to a
18、ccurate and preciselipidmeasurements. Clin Lab Med, 1989, 9:105-135.10 TheIDF consensus worldwidedefinition of themetabolic syn-drome (http:/www.idf.org/webdata/docs/IDF _ Metasyn-drome_definition.pdf).11 Obesity:preventing and managing theglobal epidemic. Reportof a WHO consultation. World Health O
19、rgan Tech Rep Ser,2000, 894:1-253.12 GU Dongfeng, Reynolds K, WU Xigui, et al. Prevalenceof theMetabolic Syndrome and Overweight Among Adults inChina.Lancet, 2005,365:1398-1405.13 WHO. Definition, diagnosisandclassificationof diabetesmelli-tus and its complications. report of aWHO Consultation. Part
20、1:diagnosis and classification of diabetes mellitus. http:/whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf.14 Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolicsyndromeand total andcardiovascular diseasemortality in mid-dle-aged men. JAMA,2002,288:2709-2716.15 ZHOU Beifan. Effect of bodymassindex
21、 on all-causemortalityandincidenceof cardiovasculardiseases-report for meta-analysisof prospectivestudies open optimal cut-off points of body massindexin Chinese adults. Biomed Environ Sci, 2002, 15:245-252.16 Chuang S, ChenC, Tsai S, et al. Clinical identification of themetabolicsyndromeinKinmen. A
22、ctaCardiolSin, 2002,18:16-23.17 7A、3h?hBy BxTF.11 8 g MS h.D, 2002, 36:298-300.18 GU Dongfeng, Reynolds K, DUAN Xiufang, et al. Prevalenceof diabetes and impaired fasting glucose in the Chinese adultpopulation:International CollaborativeStudy of CardiovascularDiseasein Asia(InterASIA). Diabetologia,
23、 2003,46:1190-1198.19 ZHOU Beifan, RAO Xuxu, Dennis BH, et al. Therelationshipbetween dietary factors and serum lipids in Chinese urban andrural populations of Beijing and Guangzhou. Int J Epidemiol,1995, 24:528-534.20 WU Xigui, HUANG Zhendong, Stamler J, et al. Changes inaverage blood pressure and
24、incidence of high blood pressure1983-1984 to 1987-1988 in four population cohorts in thePeoples Republic of China. ThePRC-USA Cardiovascular andCardiopulmonary Epidemiology Research Group. J Hypertens,1996,14:1267-1274.( l :2005-05-27) S Uh 2 TD Uhs s 3% e ,FEIS Uh 2XvD T,N20.00(c)。 “: g uv1| UhI (I:100034,:010-66515929)186 Uh2005 M13 3 Chin J Diabetes, June2005,Vol 13,No 3
